
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : LPH-5
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Biotrial
Deal Size : Inapplicable
Deal Type : Inapplicable
Study to Evaluate LPH-5 in Healthy Subjects
Details : LPH-5 is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
December 09, 2024
Lead Product(s) : LPH-5
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Biotrial
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : LPH-5
Therapeutic Area : Psychiatry/Psychology
Study Phase : Preclinical
Sponsor : Beckley Psytech
Deal Size : Undisclosed
Deal Type : Collaboration
Details : Under the terms of the agreement Beckley Psytech will jointly fund continuing development of the Lophora pipeline including it's lead candidate LPH-5 and collaborate broadly on R&D.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Undisclosed
May 11, 2022
Lead Product(s) : LPH-5
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Preclinical
Sponsor : Beckley Psytech
Deal Size : Undisclosed
Deal Type : Collaboration
